Good prediction of treatment responses to neoadjuvant chemoradiotherapy for esophageal cancer based on preoperative inflammatory status and tumor glucose metabolism

To develop a tool for predicting pathologic complete response (pCR) after neoadjuvant chemoradiotherapy (neoCRT) in patients with esophageal cancer by combining inflammatory status and tumor glucose metabolic activity. This study included 127 patients with locally advanced esophageal cancer who had...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chuan, Lin, Jing-Wei, Yeh, Hui-Ling, Chuang, Cheng-Yen, Chen, Chien-Chih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172631/
https://www.ncbi.nlm.nih.gov/pubmed/34078965
http://dx.doi.org/10.1038/s41598-021-90753-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172631/
https://www.ncbi.nlm.nih.gov/pubmed/34078965
http://dx.doi.org/10.1038/s41598-021-90753-y

Ejemplares similares